Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-27
2009-08-18
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S163000
Reexamination Certificate
active
07576217
ABSTRACT:
The present invention relates to compounds of formula Iwherein R1to R6are as described herein, which compounds are active at the GABABreceptor and can be used for the preparation of medicaments useful in the treatment of CNS disorders comprising anxiety and depression.
REFERENCES:
patent: 5641788 (1997-06-01), Sohda et al.
patent: 6313146 (2001-11-01), Van Wagenen et al.
patent: WO 03/090731 (2003-11-01), None
patent: WO 2004/043930 (2004-05-01), None
Sinsky, CA 102:45748 abstract only of J of Het Chem, vol. 21(3), pp. 759-768, 1984.
Vigante, CA 117:171184, abstract only of Khimiya Geterotsiklicheskikh Soedinenii, vol. 12, pp. 1680-1686, 1991.
Walser, CA 84:179997, abstract only of J of Het Chem, vol. 13(1), pp. 131-133, 1976.
Arcadi, CA 138:401582, abstract only of Synlett, vol. 2, pp. 203-206, 2006.
Ubeda, CA 131:228671, abstract only of Synthesis, vol. 8, pp. 1335-1340, 1999.
Yadav, Synlett, vol. 6, pp. 963-966, 2004.
Vacher et al., Curr. Drug Targets, CNS Neurol. Disord. 2, pp. 248-259, 2003.
Bettler, et al., Physiol Rev. 84, pp. 835-867, 2004.
Kaupmann et al., Nature, 386, pp. 239-246, 1997.
Kaupmann et al., Nature, 396, pp. 683-687, 1998.
Pin et al., Pharmaco. Ther. 98, pp. 325-354, 2003.
Havlickova et al., Mol. Pharmacol. 62, pp. 343-350, 2002.
Kniazeff et al., J. Neurosci., 22, pp. 7352-7361, 2002.
Schuler et al., Neuron, 31, pp. 47-58, 2001.
Peters et al., Neurogenetics, 2, pp. 47-54, 1998.
Mondabon et al., Am. J. Med. Genet 122B/1, p. 134, 2003.
Gassmann et al., J Neurosci. 24, pp. 6086-6097, 2004.
Misgeld et al., Prog. Neurobiol. 46, pp. 423-462, 1995.
Enna et al., Life Sci, 62, pp. 1525-1530, 1998.
McCarson et al., Neuropharmacology, 38, pp. 1767-1773, 1999.
Brebner et al., Neuropharmacology, 38, pp. 1797-1804, 1999.
Paterson et al., Psychopharmacology, 172, pp. 179-186, 2004.
Breslow et al., Am. J. Psychiatry, 146, pp. 353-356, 1989.
Drake et al., Ann. Pharmacother. 37., pp. 1177-1181, 2003.
Bortolato et al., Psychopharmacology, 171, pp. 322-330, 2004.
Urwyler et al., Mol. Pharmacol., 60, pp. 963-971, 2001.
Pin et al., Mol. Pharmacol., 60, pp. 881-884, 2001.
Binet et al., J Biol Chem., 279, pp. 29085-29091, 2004.
Mombereau et al., Neuropsychopharmacology, 29, pp. 1050-1062, 2004.
Urwyler et al., J. Pharmacol. Exp. Ther., 307, pp. 322-330, 2003.
Cryan et al., J Pharmacol Exp Ther., 310, pp. 952-963, 2004.
Smith et al., Psychopharmacology, 173, pp. 105-111, 2004.
Fuson, R.C., et al., J. Am. Chem. Soc., vol. 79, pp. 3477-3480 (1957) XP002367350.
Walser, A., et al., J. Heterocycl. Chem., vol. 13, pp. 131-133 (1976) XP002367351.
Sinsky, M.D., et al., J. heterocycl. Chem., vol. 21, pp. 759-768 (1984) XP002367352.
Arcadi, A., et al., Synlett., pp. 203-206 (2003) XP002367353.
Sato, Susumu, et al., Chemical Abstracts Service, XP002367441 & JP 2002 371078 A2.
Chemical Abstracts, XP002367442, Publ. Date Apr. 25, 2003.
Chemical Abstracts, XP002367443, Publ. Date Sep. 27, 2004.
Urwyler, S., et al., Molecular Pharmacology, vol. 60, No. 5, Nov. 2001, pp. 963-971 XP001153169.
Urwyler, S., et al., American Chemical Society, vol. 225, No. ½, Mar. 2003, p. MED1317 XP009029992.
Malherbe Parichehr
Masciadri Raffaello
Norcross Roger David
Ratni Hasane
Thomas Andrew William
Hoffman-La Roche Inc.
Johnston George W.
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
Seaman D. Margaret
LandOfFree
Quinolines as allosteric enhancers of the GABA B receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolines as allosteric enhancers of the GABA B receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolines as allosteric enhancers of the GABA B receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4088804